Equity financing (new-money component) · Healthtech

Virtual Incision discloses $4.02 million in new equity money alongside note conversion

The surgical-robotics company's filing separates fresh investment from $31.12 million of converted notes.

Virtual Incision reported $4,019,999.89 of new money in an equity offering disclosed on October 5, 2026. Its SEC filing separately identifies $31,120,061.08 of convertible-note conversion, which accounts for most of the roughly $35.14 million shown as securities sold.

The distinction matters because converting existing notes into equity does not deliver that amount of additional cash. The filing lists an $80,140,041 total offering and sixty investors, with the first sale dated September 18. It does not identify a venture-round stage or name the subscribers.

The Lincoln company develops MIRA, a compact robotic-assisted surgical system for use within existing operating rooms. Its tray-to-table design aims to make robotic surgery available to more hospital facilities without the footprint of a large fixed installation.

In August, Virtual Incision announced US clearance for MIRA in benign hysterectomy procedures, expanding its authorized uses beyond adult colectomy. The October financing notice gives no specific spending allocation.

Funding history

Equity financing (new-money component) · This round$4M

Sources

  1. Virtual Incision equity offering noticesec.gov · Oct 5, 2026
  2. sec.gov
  3. Virtual Incision official productvirtualincision.com
  4. virtualincision.com